Cannabinoids may influence oral diseases like cancer and gum disease through autophagy pathways, but clinical evidence is lacking
A review found that cannabinoids modulate autophagy in oral tissues by inhibiting mTOR and promoting cell recycling, with potential for oral cancer and periodontal disease, but no clinical data exists.
Quick Facts
What This Study Found
Cannabinoids acting through CB1 and CB2 receptors modulate autophagy by inhibiting PI3K/AKT/mTOR, activating AMPK and Beclin-1, and promoting ROS-induced autophagy. These mechanisms have dual anti-inflammatory and anti-cancer potential in oral tissues. Cannabinoid-induced autophagy may also enhance stem cell survival for dental pulp regeneration.
Key Numbers
Key pathways: PI3K/AKT/mTOR inhibition, AMPK activation, Beclin-1 upregulation. Receptors: CB1 and CB2. Applications: OSCC, periodontitis, gingival inflammation, dental pulp regeneration.
How They Did This
Narrative review of experimental studies on cannabinoid-autophagy interactions in oral tissues, covering oral squamous cell carcinoma, periodontitis, gingival inflammation, and dental pulp regeneration.
Why This Research Matters
Oral cancers and periodontal disease have limited treatment options. Understanding how cannabinoids interact with cellular recycling in oral tissues could open new therapeutic approaches, though this remains early-stage.
The Bigger Picture
Autophagy dysregulation drives both cancer and inflammatory disease. If cannabinoid modulation of autophagy can be targeted to oral tissues, it could be a novel treatment strategy.
What This Study Doesn't Tell Us
Primarily preclinical data. No clinical trials. Dose-dependent variability and poor oral bioavailability remain challenges.
Questions This Raises
- ?Can cannabinoid formulations achieve sufficient oral tissue specificity?
- ?How do smoking-related delivery methods affect oral disease risk?
Trust & Context
- Key Stat:
- Cannabinoids inhibit PI3K/AKT/mTOR and activate AMPK/Beclin-1 autophagy pathways in oral tissues
- Evidence Grade:
- Mechanistic review of preclinical evidence; no clinical data for oral disease applications.
- Study Age:
- 2026 publication
- Original Title:
- Cannabinoid Signaling and Autophagy in Oral Disease: Molecular Mechanisms and Therapeutic Implications.
- Published In:
- International journal of molecular sciences, 27(1) (2026)
- Authors:
- Munkhsaikhan, Undral, Rahman, Md Ataur, Shasteen, Alivia, Ait-Aissa, Karima, Sahyoun, Amal M, Gupta, Rajat Das, Kassan, Modar, Hoque Apu, Ehsanul, Abidi, Ammaar H
- Database ID:
- RTHC-08511
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Can cannabinoids treat oral cancer?
Preclinical evidence shows cannabinoids can activate cell-death pathways in oral cancer cells, but no clinical trials have tested this.
What is autophagy?
A cellular recycling process that breaks down damaged components. When dysregulated, it can contribute to cancer or inflammatory disease.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-08511APA
Munkhsaikhan, Undral; Rahman, Md Ataur; Shasteen, Alivia; Ait-Aissa, Karima; Sahyoun, Amal M; Gupta, Rajat Das; Kassan, Modar; Hoque Apu, Ehsanul; Abidi, Ammaar H. (2026). Cannabinoid Signaling and Autophagy in Oral Disease: Molecular Mechanisms and Therapeutic Implications.. International journal of molecular sciences, 27(1). https://doi.org/10.3390/ijms27010525
MLA
Munkhsaikhan, Undral, et al. "Cannabinoid Signaling and Autophagy in Oral Disease: Molecular Mechanisms and Therapeutic Implications.." International journal of molecular sciences, 2026. https://doi.org/10.3390/ijms27010525
RethinkTHC
RethinkTHC Research Database. "Cannabinoid Signaling and Autophagy in Oral Disease: Molecul..." RTHC-08511. Retrieved from https://rethinkthc.com/research/munkhsaikhan-2026-cannabinoid-signaling-and-autophagy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.